Fil LTD Karuna Therapeutics, Inc. Transaction History

Fil LTD

  • $95.5 Billion
  • Q2 2024

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
SELL
$161.01 - $317.85 $281,767 - $556,237
-1,750 Reduced 2.84%
59,885 $19 Million
Q3 2023

Nov 13, 2023
SELL
$164.66 - $218.08 $1.07 Million - $1.42 Million
-6,506 Reduced 9.55%
61,635 $10.4 Million
Q2 2023

Aug 11, 2023
SELL
$176.32 - $240.22 $6.12 Million - $8.33 Million
-34,692 Reduced 33.74%
68,141 $14.8 Million
Q1 2023

May 11, 2023
BUY
$161.33 - $204.36 $10.9 Million - $13.7 Million
67,274 Added 189.19%
102,833 $18.7 Million
Q4 2022

Feb 13, 2023
BUY
$191.53 - $236.82 $6.81 Million - $8.42 Million
35,559 New
35,559 $6.99 Million
Q3 2021

Nov 15, 2021
SELL
$101.2 - $125.87 $1.67 Million - $2.08 Million
-16,491 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$95.46 - $133.08 $1.55 Million - $2.16 Million
16,196 Added 5490.17%
16,491 $1.98 Million
Q4 2020

Feb 08, 2021
SELL
$75.23 - $109.23 $50.5 Million - $73.4 Million
-671,534 Reduced 99.96%
295 $30,000
Q3 2020

Nov 13, 2020
SELL
$71.31 - $109.74 $16.2 Million - $25 Million
-227,398 Reduced 25.29%
671,829 $51.9 Million
Q2 2020

Aug 13, 2020
BUY
$62.14 - $117.21 $17.3 Million - $32.7 Million
278,715 Added 44.92%
899,227 $100 Million
Q1 2020

May 14, 2020
BUY
$60.41 - $115.92 $20.3 Million - $39 Million
336,112 Added 118.18%
620,512 $44.7 Million
Q4 2019

Feb 07, 2020
SELL
$11.44 - $123.99 $2.97 Million - $32.2 Million
-259,298 Reduced 47.69%
284,400 $21.4 Million
Q3 2019

Nov 13, 2019
BUY
$16.05 - $27.35 $5.98 Million - $10.2 Million
372,817 Added 218.17%
543,698 $8.87 Million
Q2 2019

Aug 13, 2019
BUY
$20.02 - $20.02 $3.42 Million - $3.42 Million
170,881 New
170,881 $3.42 Million

Others Institutions Holding KRTX

# of Institutions
10
Shares Held
332K
Call Options Held
0
Put Options Held
0
View Full List

About Karuna Therapeutics, Inc.

KRTX Quotes by TradingView
  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Fil LTD Portfolio

Follow Fil LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fil LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email